Afelimomab-another therapeutic option in sepsis therapy?
Grass
Guido
G
Neugebauer
Edmund Alwin Martin
EA
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003422:Critical Care / Q000379:methods / Q000592:standards; D019317:Evidence-Based Medicine; D006801:Humans; D015850:Interleukin-6 / Q000097:blood*; D018579:Patient Selection; D018805:Sepsis / Q000097:blood* / Q000188:drug therapy* / Q000276:immunology / Q000401:mortality; D015996:Survival Rate; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D015850:Interleukin-6; C427683:afelimomab